Page 46 - 82_02

86. Garcia MA, Guerra S, Gil J, Jimenez V, Esteban M.
Antiapoptotic and oncogenic properties of the dsRNA-
binding protein of vaccinia virus, E3L. Oncogene
2002; 21:8379–8387.
87. de la Cruz-Herrera CF, Campagna M, García MA, et
al. Activation of the double-stranded RNA-dependent
protein kinase PKR by small ubiquitin-like modifier
(SUMO). J Biol Chem. 2014; 289(38):26357-67.
88. Esteban M, Garcia MA, Domingo-Gil E, Arroyo J,
Nombela C, Rivas C. The latency protein LANA2
from Kaposi’s sarcoma-associated herpesvirus inhibits
apoptosis induced by dsRNA-activated protein kinase
but not RNase L activation. J. Gen. Virol. 2003;
84:1463–1470.
89. Munoz-Fontela C, Collado M, Rodriguez E, Garcia
MA, et al. Identification of a nuclear export signal in
the KSHV latent protein LANA2 mediating its export
from the nucleus. Exp. Cell Res. 2005; 311:96–105.
90. Gomez CE, Vandermeeren A M, Garcia MA,
Domingo-Gil E, Esteban M. Involvement of PKR and
RNase L in translational control and induction of
apoptosis after hepatitis C polyprotein expression
from a vaccinia virus recombinant. Virol. J. 2005;
2:81.
91. Spurgeon ME, Ornelles DA. The adenovirus E1B 55-
kilodalton and E4 open reading frame 6 proteins limit
phosphorylation of eIF2alpha during the late phase of
infection. J Virol. 2009;83(19):9970-82.
92. Wang Z, Mir MA. Andes virus nucleocapsid protein
interrupts protein kinase R dimerization to counteract
host interference in viral protein synthesis. J
Virol. 2015; 89(3):1628-39.
93. Ikegami T, Narayanan K, Won S, Kamitani W, Peters
CJ, Makino S. Dual functions of Rift Valley fever
virus NSs protein: inhibition of host mRNA
transcription and post-transcriptional downregulation
of protein kinase PKR. Ann N Y Acad
Sci. 2009; 1171 Suppl 1:E75-85.
94. Wang X, Liao Y, Yap PL, Png KJ, Tam JP, Liu DX.
Inhibition of protein kinase R activation and
upregulation of GADD34 expression play a
synergistic role in facilitating coronavirus replication
by maintaining de novo protein synthesis in virus-
infected cells. J Virol. 2009 ; 83(23):12462-72.
95. Schümann M, Gantke T, Mühlberger E. Ebola
virus VP35 antagonizes PKR activity through its C-
terminal interferon inhibitory domain. J Virol. 2009;
83(17):8993-7.
96. Tu YC, Yu CY, Liang JJ, Lin E, Liao CL, Lin YL.
Blocking double-stranded RNA-activated protein
kinase PKR by Japanese encephalitis virus
nonstructural protein 2A. J Virol. 2012; 86(19):10347-
58.
97. Chen X, Xia J, Zhao Q, et al. Eukaryotic initiation
factor 4AI interacts with NS4A of Dengue virus and
plays an antiviral role. Biochem Biophys Res
Commun. 2015; 22;461(1):148-53.
164
María Ángel García Chaves
98. Sudha G, Yamunadevi S, Tyagi N, Das S, Srinivasan
N. Structural and molecular basis of interaction of
HCV non-structural protein 5A with human casein
kinase 1a and PKR.BMC Struct Biol. 2012; 13;12:28.
99. Dabo S, Meurs EF. dsRNA-dependent protein
kinase PKR and its role in stress, signaling and HCV
infection. Viruses. 2012;4(11):2598-635.
100. Lussignol M, Queval C, Bernet-Camard MF, et al.
The herpes simplex virus 1 Us11 protein inhibits
autophagy through its interaction with the protein
kinase PKR. J Virol. 2013;87(2):859-71.
101. Poppers J, Mulvey M, Perez C, Khoo D, Mohr I.
Identification of a lytic-cycle Epstein-Barr virus gene
product that can regulate PKR activation. J
Virol. 2003; 77(1):228-36.
102. Burýsek L, Pitha PM. Latently expressed human
herpesvirus 8-encoded interferon regulatory factor 2
inhibits double-stranded RNA-activated protein
kinase. J Virol. 2001;75(5):2345-52.
103. Bierle CJ, Semmens KM, Geballe AP. Double-
stranded RNA binding by the human
cytomegalovirus PKR antagonist TRS1. Virology.
2013; 20;442(1):28-37.
104. Sharma K, Tripathi S, Ranjan P, et al. Influenza A
virus nucleoprotein exploits Hsp40 to inhibit PKR
activation. PLoS One. 2011;6(6):e20215.
105. Min JY, Li S, Sen GC, Krug RM. A site on the
influenza A virus NS1 protein mediates both
inhibition of PKR activation and temporal regulation
of viral RNA synthesis.Virology. 2007;
20;363(1):236-43.
106. Groskreutz DJ, Babor EC, Monick MM, Varga SM,
Hunninghake GW. Respiratory syncytial virus limits
alpha subunit of eukaryotic translation initiation factor
2 (eIF2alpha) phosphorylation to maintain translation
and viral replication. J Biol Chem.
2010;285(31):24023-31.
107. Chi PI, Huang WR, Lai IH, Cheng CY, Liu HJ. The
p17 nonstructural protein of avian reovirus triggers
autophagy enhancing virus replication via activation
of phosphatase and tensin deleted on chromosome 10
(PTEN) and AMP-activated protein kinase (AMPK),
as well as dsRNA-dependent protein kinase
(PKR)/eIF2a signaling pathways. J Biol Chem. 2013;
1;288(5):3571-84.
108. Yoon CH, Kim SY, Byeon SE, et al. p53-derived
host restriction of HIV-1 replication by protein kinase
R-mediated Tat phosphorylation and inactivation. J
Virol. 2015; 89(8):4262-80.
109. Rathore AP, Ng ML, Vasudevan SG. Differential
unfolded protein response during Chikungunya and
Sindbis virus infection: CHIKV nsP4 suppresses
eIF2a phosphorylation. Virol J. 2013; 28;10:36.
110. Lee TG, Tang N, Thompson S, Miller J, Katze MG.
The 58,000-dalton cellular inhibitor of the interferon-
induced double-stranded RNA-activated protein
kinase (PKR) is a member of the tetratricopeptide
@Real Academia Nacional de Farmacia. Spain